In the Spotlight

Publication

Public Health Implications of Raising the Minimum Age of Legal Access to Tobacco Products

In 2013, as requested by the U.S. Food and Drug Administration (FDA), the IOM convened a committee to conduct a study on the public health implications of raising the minimum age to purchase tobacco products.  In the report, Public Health Implications of Raising the Minimum Age of Legal Access to Tobacco Products, the committee of experts reviews existing literature on tobacco use initiation, developmental biology and psy­chology, and tobacco policy and predicts the likely public health outcomes of raising the MLA for tobacco products to 19 years, 21 years, and 25 years.

Video